Not so many years ago, medical students and scientists had to struggle to remember only a few complex nomenclature systems, such as the complement cascade or the coagulation factors. However, our increased knowledge of different fields has created a nightmare of nomenclature and a complexity in terminology, so that even for the experts, it is becoming impossible to have a complete understanding of the terminology in their own areas. Let us take, as an example, the HLA nomenclature, which has a large number of loci encoding for more than 1500 different alleles or the natural killer and T-cell molecules or the existing numbers of cytokines and interleukins, and the complex pathways of apoptosis and intracellular signalling.
Let us not forget that the need for this complex nomenclature arose because of a need to make common sense of the multiple names generated by individual laboratories working with different antibodies on the same cell surface antigens. For example, whether the Q4 molecule was called T4 or Leu3 largely depended on which coast of the United States was being worked on or collaborated with! With many groups worldwide characterising antibodies and assigning their molecular targets individual names, it rapidly became almost impossible to learn whether individuals were working on the same or different molecules. The establishment of international cooperative workshops, where everybody shared reagents and compared results, arose as a result of a need for consensus and ultimately a universal nomenclature that is internationally approved and wellknown.
Because the nomenclature used in each field has become so large and complex, it is almost impossible to either read a paper or review a manuscript without finding nomenclature derivations or terminology that are impossible to understand, without first consulting a dictionary, reference book or an expert in a particular field. This is why books such as 'Leucocyte Typing VII' are extremely welcome by the immunological and haematological community. This book contains a joint report of the work of 500 laboratories involved worldwide in the seventh International HLDA Workshop in the evaluation of over 1000 different monoclonal antibodies against molecules on human haemopoietic cells.
The first of these workshops took place in the early 1980s and was held in Paris. At that time, only 15 molecules were identified under the CD scheme. Matters have changed since the traditional criteria for establishing a new CD specificity were defined (this is the existence of at least two independent antibodies at the same specificity). With the emergence of immunobiology and the definition of genes by which monoclonal reagents are available, it is possible now to characterise these by different laboratories and confirm their existence (this was the main objective of the Seventh International HLDA Workshop).
As a result of this collaborative new approach, the book by Mason et al. reports that over 80 new entities have been added to the list of CD specificities, which is substantially more than the usual average of 13 new specificities per workshop. It is also very interesting to see that from the original concept of looking only at molecules on the leucocyte cells, the CD nomenclature has now been extended to all the haematopoietic cells including dendritic cells, progenitor stem cells and red cells. In addition, there is a new section on carbohydrate structures. These new inclusions are justified because there are several molecules that are shared between white and red cells.
All the sections of the book are comprehensively covered. Part 1 describes the CD molecules for adhesion structures, Part 2 describes apoptosis and cell fate, and Part 3 has an extensive and comprehensive analysis on B cells. In Part 4 there is a section that describes the analysis of a blind panel study on carbohydrate and lectin molecules, as well as miscellaneous studies. Part 5 is extremely interesting as it describes the clinical aspects of leucocyte molecules, which is followed by a section on cytokine and chemokine receptors in Part 6. There is a section on dendritic cells and endothelial cells in Parts 7 and 8, and Part 9 deals with myeloid cells. I found Part 10 on new technology extremely interesting and Part 11 discusses natural killer cells, a component that is becoming extremely complex.
In addition, there are sections describing molecules on nonlineage antigens, platelets (Part 13), red cells (Part 14) and progenitor stem cells (Part 15). Part 15 contains some very interesting papers on epitope classification of the CD34 antibody panel and the expression of CD44 variants on different sources of human haematopoietic stem cells from cord blood, child thymus and adult mobilised peripheral blood cells. Finally, Part 16 deals with the structure and functional aspects of leucocyte molecules, and Part 17 with T cells. Each part has, in general, an introduction and an overview of each component and then reports on several molecules, either describing a novel CD molecule or defining the characterisation of a particular epitope. Thus, when looking at a particular molecule for a cell lineage, access is easy and comprehensive.
On the other hand, one has to wonder about the role of CD nomenclature. There is no doubt that this way of describing a molecule is valid and useful; however, it does not convey information as to the function of a structure of genes or, indeed, their family relationship. The use of terminology, such as 'ICAM-1', means something to everyone as it describes the molecule family, whereas 'CD54' may be meaningless. The CD names for the killer immunoglobulin-like receptor (KIR) gene, referred to here as CD158, is an example of where the usefulness of the CD nomenclature breaks down. The Human Genome Nomenclature Committee has assigned names to these genes, so that both the structure and function of the gene's products are indicated. The names assigned to these genes are widely used within the field; therefore it seems both unnecessary and confusing to assign a second series of names to the same molecules.
This book is extremely well presented, complete and easy to review, as the description of each CD molecule is short and substantiated by several good references. I can therefore recommend this book to both immunologists and haematologists working in the field, who are trying to understand the complexity of the CD system.
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